Abstract
Particular human papillomavirus (HPV) subtypes are implicated in the genesis of abnormal cervical cytology and cervical cancer. While most immunocompetent hosts clear HPV infection with no sequelae, some develop premalignant cytological changes of whom a minority subsequently progress to overt carcinoma. Immunocompromised patients, such as renal allograft recipients and HIV-infected individuals, have a higher rate of cytological abnormalities. This is thought to be due to prolonged persistence of virus due to impaired clearance by the immune system. We undertook a retrospective review of the cervical cytology of all women who underwent BMT at two transplant centres and who had cervical smears performed between 1990 and 1998. The rate of cytological abnormalities was significantly higher than in the general population before BMT (age-adjusted odds ratio (OR) 2.2, P = 0.02) and after BMT (OR 7.0, P < 0.0001). After BMT, allogeneic recipients had a higher rate of abnormalities than did autologous patients (OR 2.6, P = 0.02) although only allogeneic recipients had a higher rate of abnormalities post-BMT compared to pre-BMT (allogeneic OR 6.8, P = 0.004). These observations suggest that pre-transplant disease and treatment factors increase the risk of cytologic abnormalities and that transplant-related factors such as conditioning therapy and immunosuppression further increase this risk. These data suggest that more frequent screening may be required in these at-risk groups, especially allogeneic recipients. Prospective studies are required to further evaluate cytological abnormalities and HPV shedding in these populations. Bone Marrow Transplantation (2001) 28, 393–397.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Koutsky L . Epidemiology of genital human papillomavirus infection Am J Med 1997 102: (Suppl. 5A) 3–8
Bauer HM, Ting Y, Greer CE et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method JAMA 1991 265: 472–477
Schiffman MH . Recent progress in defining the epidemiology of human papillomavirus infection and cervical neoplasia J Natl Cancer Inst 1992 84: 394–398
Lowy DR, Kirnbauer R, Schiller JT . Genital human papillomavirus infection Proc Natl Acad Sci USA 1994 91: 2436–2440
Zaki SR, Judd R, Coffield LM et al. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridisation and the polymerase chain reaction Am J Pathol 1992 140: 1345–1355
Bosch FX, Manos MM, Munoz N et al. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) Study Group J Natl Cancer Inst 1995 87: 796–802
Meisels A . Cytological diagnosis of human papillomavirus. Influence of age and pregnancy stage Acta Cytol 1992 36: 480–482
Barber H . Incidence, Prevalence, and Median Survival Rates of Gynaecological Cancer John Wright-PSG: Boston 1982
Ho GY, Bierman R, Beardsley L et al. Natural history of cervicovaginal papillomavirus infection in young women New Engl J Med 1998 338: 423–428
Halpert R, Fruchter RG, Sedlis A et al. Human papillomavirus and lower genital neoplasia in renal transplant patients Obstet Gynecol 1986 68: 251–258
Alloub MI, Barr BB, McLaren KM et al. Human papillomavirus infection and cervical intraepithelial neoplasia in women with renal allografts Br Med J 1989 298: 153–156
Ogunbiyi OA, Scholefield JH, Raftery AT et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients Br J Surg 1994 81: 365–367
Sun XW, Kuhn L, Ellerbrock TV et al. Human papillomavirus infection in women infected with the human immunodeficiency virus New Engl J Med 1997 337: 1343–1358
Sterrett G . The Australian (modified Bethesda) system for reporting gynaecological (cervical) cytology Cytoletter 1996 23–27
The Bethesda System for reporting cervical/vaginal cytologic diagnoses: revised after the second National Cancer Institute Workshop, 29–30 April 1991 Acta Cytologica 1993 37: 117–124
Atkinson K . Reconstruction of the haemopoietic and immune systems after marrow transplantation Bone Marrow Transplant 1990 5: 209–226
Han CS, Miller W, Haake R, Weisdorf D . Varicella zoster infection after bone marrow transplantation: incidence, risk factors and complications Bone Marrow Transplant 1994 13: 277–283
USPHS/IDSA prevention of opportunistic infections working group 1997 . USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus Morb Mortal Wkly Rep 1997 46: 1–46
Acknowledgements
We wish to acknowledge the assistance of Graham Byrnes of the Victorian Infectious Diseases Reference laboratory.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sasadeusz, J., Kelly, H., Szer, J. et al. Abnormal cervical cytology in bone marrow transplant recipients. Bone Marrow Transplant 28, 393–397 (2001). https://doi.org/10.1038/sj.bmt.1703141
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1703141
Keywords
This article is cited by
-
Endoplasmic reticulum stress enhances the antigen-specific T cell immune responses and therapeutic antitumor effects generated by therapeutic HPV vaccines
Journal of Biomedical Science (2019)
-
Solid tumors after hematopoietic stem cell transplantation in Japan: incidence, risk factors and prognosis
Bone Marrow Transplantation (2005)